City

Atlanta (1)

Columbus (1)

Duarte (1)

Minneapolis (1)

Seattle (1)

Winston-Salem (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

City of Hope Medical Center (1)

Wake Forest University Health Sciences (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

cefepime hydrochloride (1)

cmvpp65-a*0201 peptide vaccine (1)

laboratory biomarker analysis (1)

placebo (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

adult hodgkin lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

Active, not recruiting

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
+13 more

CMVpp65-A*0201 peptide vaccine
+2 more

Duarte, California
+4 more

Jan 4, 2023

Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Burkitt Lymphoma Trial in Winston-Salem (cefepime HCl)

Completed

Adult Acute Lymphoblastic Leukemia
+38 more

cefepime hydrochloride

Winston-Salem, North Carolina

Wake Forest University Health Sciences

Jul 16, 2018